Is LSL Pharma Group Inc halal to invest in?

According to Musaffa's Shariah screening methodology, LSL Pharma Group Inc (LSL.V) is currently classified as NOT HALAL as of June 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is LSL Pharma Group Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes LSL Pharma Group Inc using these criteria to determine its compliance status.

Can Muslims buy shares of LSL Pharma Group Inc?

Muslim investors may consider investing in LSL Pharma Group Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is LSL Pharma Group Inc classified as NOT HALAL?

Musaffa determines the Shariah status of LSL Pharma Group Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for LSL Pharma Group Inc updated?

The Shariah compliance status of LSL Pharma Group Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like LSL Pharma Group Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of LSL Pharma Group Inc?

You can check the latest Shariah compliance status of LSL Pharma Group Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

LSL.V Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: June 30, 2025

Report Source: 2025 1st Quarter Report

LSL Pharma Group Inc. Stock Analysis LSL.V

Canada Consumer Staples Nano Cap Report: Q1, 2025

LSL Pharma Group, Inc. operates as a pharmaceutical company. The company is headquartered in Boucherville, Quebec. The company went IPO on 2011-03-08. Its segments include CMO activities and Integrated Eye-care pharmaceutical company. Its wholly owned subsidiaries include Steri-Med Pharma Inc. (Steri-Med), LSL Laboratory Inc. (LSL Laboratory), Virage Sante Inc., Dermolab Pharma Ltd. (Dermolab), Du-Var Laboratory Inc. and Juno OTC Inc. (Juno OTC). LSL Laboratory manufactures natural health products in solid dosage forms, mainly for third-party pharmaceutical clients, as well as a list of private labelled products. Dermolab manufactures liquid and semi-solid pharmaceutical, natural health and cosmetic products. Steri-Med is its sterile Eye-care manufacturing operation. Juno OTC is a supplier in Canadian private label consumer healthcare OTC market.

Key Statistics of LSL Pharma Group Inc (LSL.V)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.35CAD0.36

Today's Open

CAD0.36

Volume

175.03K

P/E Ratio (TTM)

52 Week Range

CAD0.33CAD0.56

Market Cap

50.06M

Avg. Volume

92.91K

Dividend Yield

Financial Metrics & Statements of LSL Pharma Group Inc (LSL.V)

FAQ's for LSL Pharma Group Inc (LSL.V)

According to Musaffa’s Shariah screening methodology, LSL Pharma Group Inc (LSL.V) is currently classified as NOT HALAL as of June 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.